(Use MPC login credentials, the same you use to download your SA Heart congress CPD, or to participate in SA Heart nomination and voting. If you don’t have one yet, register a user login.)
Click on "Journal CPD" (Top row tab)
Find the SA Heart Journal, click on "Access"
Provide your SA Heart membership number (you can find this on your SA Heart member profile, using your email address to login on www.saheart.org ) or on your membership invoice.
Once you have provided your membership number, you will be able to access the journal and questionnaire and submit it once completed.
Performance-enhancing drugs, supplements and the athlete’s heart
Andrew Pipe
Abstract
The use of performance-enhancing drugs is an unfortunatereality of contemporary sport. It would be a mistake tobelieve that this is a phenomenon found only in elite sport.Athletes at all levels and young adults may be tempted toaccentuate performance or physique with prohibited drugsor products marketed as supplements. No defined populationsof users ingesting known quantities of known substances are generally available for study. Many of these products have been associated with adverse health effects; cardiac structure and function are known to be affected by many of the products commonly abused. Changes to the lipoprotein profile, propensity for coagulation, coronary circulation, and ventricular function may accompany the use of many performance-enhancing compounds and methods. Anabolic steroids, other peptide hormones, stimulants, erythropoietin and blood doping, have all been associated with significant cardiovascular consequences. So-called nutritional supplements aggressively marketed to the athletically inclined, are available over the Internet and typically totally unregulated in the country of their origin. Clinicians should be aware of the problems that such drug use can engender, and be sensitive to the possibilities of such abuse in caring for athletes and young patients, particularly in those presenting with unusual or unanticipated cardiovascular signs and symptoms.
Disclaimer: This journal is hosted by the SU LIS on request of the journal owner/editor. The SU LIS takes no responsibility for the content published within this journal, and disclaim all liability arising out of the use of or inability to use the information contained herein. We assume no responsibility, and shall not be liable for any breaches of agreement with other publishers/hosts.